An evergreen fund based in New York and Cambridge typically invests between $500K to $3M. The firm seeks investment opportunities globally.
The firm is interested in medical devices, diagnostics, and therapeutics from early-stage to commercial-stage. Current investments include applications for the rapid detection of pathogens, oral photo-medicine, point-of-care diagnostics, and a novel use of up converting nanocrystals.
The firm does not have a management team requirement.
If you are interested in more information about this investor and other investors tracked by LSN, please email mandates@lifesciencenation.com
Leave a Reply